A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/1993
12/06/1993	EP0608217A4 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition.
12/05/1993	CA2097671A1 Heterocyclic derivatives
12/01/1993	EP0572190A1 Ophthalmic compositions containing vitamin E or ester thereof as an active ingredient
12/01/1993	EP0571928A1 Acyclic Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
12/01/1993	EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
12/01/1993	EP0571602A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
12/01/1993	EP0491001B1 New diphosphonic acid derivatives containing amidine groups, process for preparing them and drugs containing these compounds
12/01/1993	EP0473626B1 New diphosphonic acid derivatives, process for producing them and drugs containing them
12/01/1993	EP0406324B1 Hematopoietic colony-stimulating factors improve the lipoprotein cholesterol profile
11/1993
11/30/1993	US5266685 Non-bitter protein hydrolyzates
11/30/1993	US5266591 Ethanolamine benzoate compounds
11/30/1993	US5266582 2,4-thiazolidinedione compounds
11/30/1993	US5266565 Vanadium complexes
11/30/1993	US5266561 Treatment of type 2 diabetes mellitus
11/30/1993	CA2096496A1 Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
11/30/1993	CA1324761C 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
11/27/1993	CA2096902A1 Ophthalmic compositions containing vitamin e or ester thereof as an active ingredient
11/25/1993	WO1993023375A1 Substituted pyridines, their preparation and pharmaceutical use
11/25/1993	WO1993023071A1 Use of igf-1
11/25/1993	WO1993023069A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
11/25/1993	WO1993023030A1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids
11/25/1993	WO1993023027A1 Use of alpha-ketoglutarate
11/25/1993	WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/25/1993	CA2134563A1 Substituted pyridines, their preparation and pharmaceutical use
11/25/1993	CA2113279A1 Use of alpha-ketoglutarate
11/25/1993	CA2112358A1 Use of igf-1
11/24/1993	EP0571253A1 Benzimidazole derivatives with antidiabetic and antiplatelet aggregation activity
11/24/1993	EP0571243A1 Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them
11/24/1993	EP0571219A2 Esterified propoxylated glycerin fat substitute compositions resistant to gastrointestinal side effects
11/24/1993	EP0570791A2 Low caloric density enteral formulation designed to reduce diarrhoea in tube-fed patients
11/24/1993	EP0570706A1 Aryl and heteroaryl (phosphinylmethyl) phosphonate squalene synthetase inhibitors and method
11/24/1993	EP0570380A1 Novel methylenebisphosphonic acid derivatives
11/24/1993	EP0563301A4 Alteration of rate and character of hair growth
11/24/1993	CN1022832C Preparation of 3-substituted-2-oxindole derivatives
11/24/1993	CN1022831C Preparation of lactone compound
11/24/1993	CN1022828C Process for preparation of aryloxy-arylthio-heteroaryloxy-heteroarylthio-alkenylene derivatives of amines
11/23/1993	US5264454 Certain 2-oxo-tetrahydro-cycloalkyl-benzopyran-3yl ureas having acyl-CoA-cholesterol acyl transferase inhibitory activity
11/23/1993	US5264441 Anticholesterol agents
11/23/1993	US5264425 Glycosaminoglycan salts and pharmaceutical compositions containing them
11/23/1993	US5264225 Silicon-containing environment-protective agent adsorbing radioactive metal isotopes and toxic heavy metals and a pharmaceutical composition containing same
11/21/1993	CA2096196A1 Pharmaceutical compositions
11/21/1993	CA2096152A1 Esterified propoxylated glycerin fat substitute compositions resistant to gastrointestinal side effects
11/20/1993	CA2096475A1 Benzimidazole derivatives; process for their preparation and pharmaceutical compositions containing them
11/19/1993	CA2096406A1 Thiochromanic compounds, method of preparation thereof and pharmaceutical compositions containing them
11/19/1993	CA2095279A1 Aryl and heteroaryl (phosphinylmethyl) phosphonate squalene synthetase inhibitors and method
11/18/1993	EP0570245A2 Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
11/18/1993	EP0570232A2 Microporous polysulfone supports suitable for removal of low density lipoprotein-cholesterol
11/18/1993	EP0570091A1 Anthraquinone derivatives, process for their preparation and their use as medicaments
11/18/1993	EP0569564A1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors
11/18/1993	EP0569443A1 Novel peptide
11/18/1993	EP0362272B1 Method and compositions for making acsf and acsf antagonists
11/17/1993	CN1078399A Health-care medicament for rehabilitating function
11/17/1993	CN1022754C Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds preparation method
11/16/1993	US5262439 Soluble analogs of probucol
11/16/1993	US5262430 Antidiabetic agent lowers blood glucose in mammals in type 2 non insulin dependent diabetes
11/16/1993	US5262419 Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
11/16/1993	CA2096281A1 Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
11/16/1993	CA1324383C Process for the manufacture of novel substituted aminomethanediphosphonic acids
11/15/1993	CA2095424A1 Microporous polysulfone support suitable for removal of low density lipoprotein-cholesterol
11/11/1993	WO1993022304A1 Phenylderivate as inhibitors of atp citrate lyase
11/11/1993	WO1993022271A1 Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
11/11/1993	WO1993021946A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
11/11/1993	WO1993021937A1 Non-bitter protein hydrolyzates
11/11/1993	WO1993021914A1 Soluble analogs of probucol
11/11/1993	WO1993021913A1 Anti-obesity drugs
11/11/1993	WO1993021783A1 Methods of treating obesity with purine related compounds
11/11/1993	CA2404943A1 Soluble analogs of probucol
11/11/1993	CA2134658A1 Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
11/11/1993	CA2134657A1 Methods of treating obesity with purine related compounds
11/11/1993	CA2118128A1 Non-bitter protein hydrolyzates
11/10/1993	EP0568687A1 Novel amylin antagonist peptides and uses therefor
11/10/1993	EP0568608A1 Arachidonic acid and methods for the production and use thereof
11/10/1993	EP0568606A1 Microbial oils and uses thereof
11/10/1993	EP0568553A1 Bridged cyclic ketal derivatives
11/10/1993	EP0568545A1 Method of reducing elevated blood sugar levels in humans
11/10/1993	EP0568540A1 2,4-DIOXO-PYRIDO 2,3-d]PYRIMIDINE-3-ACETIC ACIDS AND ESTERS AND SALTS THEREOF
11/10/1993	EP0516704B1 Novel insulin compositions
11/09/1993	US5260440 Pyrimidine derivatives
11/09/1993	US5260421 Site-directed mutagenesis modified glycoprotein hormones
11/09/1993	US5260336 Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
11/09/1993	US5260329 Angiogenesis inhibitors
11/09/1993	US5260275 Glibenclamide and tolbutamide for treating non-insulin dependent, or type 2, diabetes mellitus; enhance plasma concentration of amylin
11/09/1993	CA1324155C Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/03/1993	EP0567997A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical
11/03/1993	EP0567626A1 Amylin agonist peptides and uses therefor
11/03/1993	EP0567481A1 Cosmetic or pharmaceutical preparation
11/03/1993	EP0374188B1 Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/03/1993	EP0357788B1 Pyridazinone derivatives
11/02/1993	US5258382 Tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
11/02/1993	US5258287 DNA sequences and hybrids
10/1993
10/31/1993	CA2095206A1 4- or 5-(sulf)imido- and -(sulfon)amidopyridines and their pyridine n-oxides, processes for their preparation, and their use as medicaments
10/28/1993	WO1993021328A1 Polypeptides having kinase activity, their preparation and use
10/28/1993	WO1993021219A1 Endothelin antagonists ii
10/28/1993	WO1993021180A1 Acylaminoindole derivatives as 5-ht1 agonists
10/28/1993	WO1993021177A1 Indole derivatives as 5-ht1-like agonists
10/28/1993	WO1993021173A1 Taxol derivatives
10/28/1993	WO1993021170A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same
10/28/1993	WO1993021166A1 Heterocyclic compounds and their use in the treatment of type ii-diabetes
10/28/1993	WO1993021147A1 Method of administering pyruvate and methods of synthesizing pyruvate precursors
10/28/1993	WO1993020831A1 Method of treatment of hiv-seropositive individuals with dietary whey proteins

1 ... 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 ... 1298